Zachary L. Bernstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zachary L. Bernstein has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Adam Abraham
Department of Orthopaedics, University of Michigan, Ann Arbor, Mich, USA
1 shared publicationAlexander J. Schupper
Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA
1 shared publication- Alexander J. Vervaecke
Hôpital Ambroise-Paré, Boulogne Billancourt, France
1 shared publication - Alice H. Huang
Columbia University
1 shared publication Amir P Divanbeighi Zand
Nuffield Department of Surgical Sciences, Oxford University, Oxford, UK
1 shared publicationAmmar Kheder
Department of Neurology, Emory University, Atlanta, GA, USA
1 shared publication
Latest Publications
- 7 November 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 259, 109221
The sleep gap in deep brain stimulation in psychiatry: A systematic review
- 7 November 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 259, 109221
The sleep gap in deep brain stimulation in psychiatry: A systematic review
- 21 July 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 97 (4) , e120-e121
Letter: The Bibliometric Evolution of Neurosurgery Publications From 1977 to 2023
- 21 July 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 97 (4) , e120-e121
Letter: The Bibliometric Evolution of Neurosurgery Publications From 1977 to 2023
- 7 April 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 167, 110389
Long-term seizure reduction in generalized epilepsy after anterior nucleus of the thalamus stimulation
- 7 April 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 167, 110389
Long-term seizure reduction in generalized epilepsy after anterior nucleus of the thalamus stimulation
- Open Access
- 21 July 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 252
Solitary metastasis to the skull as the first sign of hepatocellular carcinoma in a patient in long-term remission
Hepatocellular carcinoma (HCC) is a common malignant tumor with a 5-year survival rate of 10%, presenting with extrahepatic metastases in 15-17% of patients. HCC-bone metastases represent approximately one-quarter of all HCC metastases, most frequently in the spine, pelvis, ribs, or femur. HCC-skull metastases, however, make up 0.4-1.6% of all HCC- bone metastases. Furthermore, solitary HCC-skull metastasis without known active primary HCC is an unusual presentation warranting further review and consideration. Here, the authors report a unique case of a solitary HCC-skull metastasis in a patient without known active cancer but in long-term remission for HCC. The patient is a 69-year-old male with past HCC who presented with a nontender skull mass. A computed tomography scan showed a heterogeneously enhancing mass centered in the high left parietal bone with intracranial extension. There was a noted mass effect on the left posterior frontoparietal region without worrisome midline shift. Pathology ultimately revealed the mass to be metastatic HCC. To aid in the understanding and clinical management of this rare presentation, we reviewed the literature regarding clinical presentation, radiological features, pathology, and outcome. Ultimately, early detection of the primary source of cancer is pivotal to successful treatment and prognosis, and skull lesions such as these must include HCC in the differential diagnosis.
- 21 July 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 252
Open AccessSolitary metastasis to the skull as the first sign of hepatocellular carcinoma in a patient in long-term remission
Hepatocellular carcinoma (HCC) is a common malignant tumor with a 5-year survival rate of 10%, presenting with extrahepatic metastases in 15-17% of patients. HCC-bone metastases represent approximately one-quarter of all HCC metastases, most frequently in the spine, pelvis, ribs, or femur. HCC-skull metastases, however, make up 0.4-1.6% of all HCC- bone metastases. Furthermore, solitary HCC-skull metastasis without known active primary HCC is an unusual presentation warranting further review and consideration. Here, the authors report a unique case of a solitary HCC-skull metastasis in a patient without known active cancer but in long-term remission for HCC. The patient is a 69-year-old male with past HCC who presented with a nontender skull mass. A computed tomography scan showed a heterogeneously enhancing mass centered in the high left parietal bone with intracranial extension. There was a noted mass effect on the left posterior frontoparietal region without worrisome midline shift. Pathology ultimately revealed the mass to be metastatic HCC. To aid in the understanding and clinical management of this rare presentation, we reviewed the literature regarding clinical presentation, radiological features, pathology, and outcome. Ultimately, early detection of the primary source of cancer is pivotal to successful treatment and prognosis, and skull lesions such as these must include HCC in the differential diagnosis.
- 1 September 2022
- Published by Elsevier in The Journal of Hand Surgery
- Vol. 47 (9) , 902.e1-902.e6
An Analysis of Profundus Tendon Repairs After Distal Phalanx Amputation in a Cadaveric Model of Little Finger Superficialis Deficiency
- 1 September 2022
- Published by Elsevier in The Journal of Hand Surgery
- Vol. 47 (9) , 902.e1-902.e6
An Analysis of Profundus Tendon Repairs After Distal Phalanx Amputation in a Cadaveric Model of Little Finger Superficialis Deficiency
- 4 June 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 31 (11) , 2366-2380
Tendon progenitor cells as biological augmentation improve functional gait and reduce scar formation after rotator cuff repair
- 4 June 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 31 (11) , 2366-2380
Tendon progenitor cells as biological augmentation improve functional gait and reduce scar formation after rotator cuff repair